Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, and High-Income Countries: A Systematic Review.

Autor:	Purba AKR; Division of Pharmacology and Therapy, Department of Anatomy Histology and Pharmacology, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.; Department of Health Science, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Medical Education Master Program, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Rosyid AN; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Handayani S; Department of Public Health and Preventive Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Rachman BE; Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Romdhoni AC; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Al Farabi MJ; Department of Cardiology and Vascular Medicine, Universitas Airlangga/Soetomo General Hospital, Surabaya, East Java, Indonesia., Wahyuhadi J; Department of Neurosurgery, Faculty of medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Prananingtias R; Department of Medical Record, Universitas Airlangga Hospital, Surabaya, East Java, Indonesia., Rahayu AN; Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia., Alkaff FF; Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.; Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands., Azmi YA; Department of Urology, Faculty of Medicine, Universitas Airlangga-Dr. Soetomo General Academic Hospital, Surabaya, East Java, Indonesia.; Department Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Prasetyo S; Department of Biostatistic and Population Studies, Faculty of Public Health, Universitas Indonesia, Depok, West Java, Indonesia., Nadjib M; Department of Health Administration and Health Policy, Faculty of Public Health, Universitas Indonesia, Depok, West Java, Indonesia., Gutjahr LP; Faculty of Medicine, Saarland University, Saarbrücken, Germany., Humaidy RF; Department of Public Health and Preventive Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.
Jazyk:	angličtina
Zdroj:	Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2024 Apr 21; Vol. 30, pp. e943863. Date of Electronic Publication: 2024 Apr 21.
DOI:	10.12659/MSM.943863
Abstrakt:	BACKGROUND Economic evaluation of the testing strategies to control transmission and monitor the severity of COVID-19 after the pandemic is essential. This study aimed to review the economic evaluation of COVID-19 tests and to construct a model with outcomes in terms of cost and test acceptability for surveillance in the post-pandemic period in low-income, middle-income, and high-income countries. MATERIAL AND METHODS We performed the systematic review following PRISMA guidelines through MEDLINE and EMBASE databases. We included the relevant studies that reported the economic evaluation of COVID-19 tests for surveillance. Also, we input current probability, sensitivity, and specificity for COVID-19 surveillance in the post-pandemic period. RESULTS A total of 104 articles met the eligibility criteria, and 8 articles were reviewed and assessed for quality. The specificity and sensitivity of COVID-19 screening tests were reported as 80% to 90% and 40% to 90%, respectively. The target population presented a mortality rate between 0.2% and 19.2% in the post-pandemic period. The implementation model of COVID-19 screening tests for surveillance with a cost mean for molecular and antigen tests was US$ 46.64 (min-max US $0.25-$105.39) and US $6.15 (min-max US $2-$10), respectively. CONCLUSIONS For the allocation budget for the COVID-19 surveillance test, it is essential to consider the incidence and mortality of the post-pandemic period in low-income, middle-income, and high-income countries. A robust method to evaluate outcomes is needed to prevent increasing COVID-19 incidents earlier.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu